468 filings
4
Struthers Richard Scott
10 May 24
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
4:57pm
144
CRNX
Crinetics Pharmaceuticals Inc
10 May 24
Notice of proposed sale of securities
12:40pm
10-Q
2024 Q1
CRNX
Crinetics Pharmaceuticals Inc
Quarterly report
9 May 24
4:38pm
8-K
CRNX
Crinetics Pharmaceuticals Inc
9 May 24
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results
4:12pm
8-K
CRNX
Crinetics Pharmaceuticals Inc
8 May 24
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
5:00pm
144
9q6dy0eogb9pi
8 May 24
Notice of proposed sale of securities
4:19pm
ARS
9lumm8
25 Apr 24
Annual report to shareholders
4:50pm
DEFA14A
psf48mk8t3z7q1c
25 Apr 24
Additional proxy soliciting materials
4:48pm
4
7nufrc4ncl
22 Apr 24
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
5:23pm
4
v8vsp399
17 Apr 24
Crinetics Pharmaceuticals / Dana Pizzuti ownership change
4:36pm
4
xtqibjete4fb 0s
17 Apr 24
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
4:30pm
144
buigid
15 Apr 24
Notice of proposed sale of securities
4:17pm
4
02p9qrg cxtv2zt
8 Apr 24
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
5:09pm
8-K
ic9p eibwp0oc
4 Apr 24
Departure of Directors or Certain Officers
4:52pm
144
o34cj6 sjnfvwdkh
4 Apr 24
Notice of proposed sale of securities
4:17pm
4
10ocgia93e6x3hrk99
2 Apr 24
Crinetics Pharmaceuticals / Stephanie Okey ownership change
4:35pm
144
1nlt8ce75a2jzvyh9
28 Mar 24
Notice of proposed sale of securities
4:55pm
4
e75ft
26 Mar 24
Crinetics Pharmaceuticals / Jeff E. Knight ownership change
4:30pm
4
dy8iz6 1q
22 Mar 24
Crinetics Pharmaceuticals / Dana Pizzuti ownership change
4:52pm